13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2021-01-27 Event — SEC 0001193125-21-019026 →

Frazier Life Sciences IX, L.P. → Passage BIO, Inc. PASG

Stake: — Shares: —
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%
  • Passive Schedule 13G filer baseline
  • Moderate short days-to-cover (3.5 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
6 transactions
2 buys · 2 sales · 2 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
6 filings by this filer
5 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 3.47
68,917 shares short · -24.1% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-03-16 Borthwick Kathleen officer Award 15,610 $7.64 $119K
2026-03-16 Chou William director, officer Award 58,000 $7.64 $443K
2026-01-08 Chou William director, officer Option exercise 10,000 — —
2026-01-08 Borthwick Kathleen officer Option exercise 5,000 — —
2026-01-08 Chou William director, officer Sale 4,076 $18.44 $75K
2026-01-08 Borthwick Kathleen officer Sale 2,062 $18.44 $38K

Other 13D/G Filings on Passage BIO, Inc.

FiledFormFilerStakeShares
2026-07-02 SCHEDULE 13D Lynx1 Capital Management LP 21.00% 673,759 view →
2026-06-25 SCHEDULE 13G Baselake Partners, LP — — view →
2025-07-21 SCHEDULE ORBIMED ADVISORS LLC 7.82% 243,878 view →
2024-04-12 SC ORBIMED ADVISORS LLC — — view →

Other Filings by Frazier Life Sciences IX, L.P.

FiledFormIssuerStakeShares
2026-01-27 SCHEDULE Mirum Pharmaceuticals, Inc. MIRM 6.80% 4,108,404 view →
2023-09-05 SC Mirum Pharmaceuticals, Inc. MIRM — — view →
2022-09-26 SC Phathom Pharmaceuticals, Inc. PHAT — — view →
2020-12-18 SC Mirum Pharmaceuticals, Inc. MIRM — — view →
2020-04-29 SC Mirum Pharmaceuticals, Inc. MIRM — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →